Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.69	8.74	12.62	13.16	63.46	16.46
Short-Term Investments	59.72	43.22	14.53	29.14	5.99	27.8
Cash & Short-Term Investments	74.41	51.96	27.15	42.3	69.45	44.26
Cash Growth	57.49%	91.40%	-35.82%	-39.09%	56.92%	-43.24%
Accounts Receivable	0.09	0.08	0.03	0.59	0.51	-
Other Receivables	0.17	0.14	0.04	0.05	0.03	0.09
Receivables	0.26	0.22	0.06	0.63	0.54	0.09
Prepaid Expenses	0.33	0.47	0.38	0.43	0.45	0.4
Other Current Assets	0.78	1.76	0.37	0.29	0.87	0.59
Total Current Assets	75.78	54.41	27.96	43.66	71.31	45.34
Property, Plant & Equipment	1.26	1.33	1.39	2.57	3.64	2.55
Long-Term Investments	11.79	12.54	16.12	21.88	34.27	37.23
Other Long-Term Assets	0.63	0.63	0.09	0.13	0.24	0.41
Total Assets	89.46	68.91	45.55	68.24	109.46	85.53
Accounts Payable	3.14	2.58	1.53	1.98	1.57	3.47
Accrued Expenses	4.67	3.44	3.73	7.39	6.96	7.42
Current Portion of Leases	0.36	0.19	1.37	1.23	1.05	1.08
Other Current Liabilities	0.35	29.2	0.25	0.16	0.12	0.18
Total Current Liabilities	8.51	35.4	6.87	10.75	9.69	12.15
Long-Term Leases	0.73	0.94	-	1.37	2.6	1.23
Total Liabilities	9.23	36.34	6.87	12.13	12.29	13.38
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	471.18	430.86	374.36	364.36	361.67	295.28
Retained Earnings	-389.82	-397.01	-334.72	-307.69	-266.38	-223.14
Comprehensive Income & Other	-1.15	-1.29	-0.97	-0.56	1.87	0
Total Common Equity	80.23	32.57	38.68	56.12	97.16	72.15
Shareholders' Equity	80.23	32.57	38.68	56.12	97.16	72.15
Total Liabilities & Equity	89.46	68.91	45.55	68.24	109.46	85.53
Total Debt	1.08	1.12	1.37	2.6	3.65	2.31
Net Cash (Debt)	73.32	50.84	25.78	39.7	65.8	41.95
Net Cash Growth	57.53%	97.25%	-35.08%	-39.67%	56.87%	-43.91%
Net Cash Per Share	1.03	0.83	0.54	0.85	1.57	1.42
Filing Date Shares Outstanding	74.51	68.14	49.04	46.57	46.55	38.31
Total Common Shares Outstanding	74.51	67.9	49.04	46.55	46.55	28.37
Working Capital	67.28	19.01	21.09	32.91	61.62	33.19
Book Value Per Share	1.08	0.48	0.79	1.21	2.09	2.54
Tangible Book Value	80.23	32.57	38.68	56.12	97.16	72.15
Tangible Book Value Per Share	1.08	0.48	0.79	1.21	2.09	2.54
Machinery	2.81	2.69	2.85	2.82	2.62	2.61
Leasehold Improvements	0.03	2.08	2.08	2.08	2.08	2.08

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q